Pre-Commercialization

Customers today are bombarded with new innovations and they need to see beyond the tech hype to understand how that solution solves their own pain point and what value they can place on it to justify spending their precious resources on it. Its a world where you have 1 shot to impress your healthcare customer, and we work with you to maximize your chances and help shorten the sales cycle. We do it in two areas:
Product Value Story
We help unlock the power of your solution with the right positioning for Payers, Providers and Patients by framing the benefits in healthcare decision-makers’ language (Clinical, Economic, and Experience—“C.E.X” model).
Why its important:
Competitive Positioning: Differentiate against existing solutions.
Evidence-based Storytelling: Leverage data, case studies, and outcomes to build credibility.
What you can expect :
-
Compelling Value Storyline for Buyers (Hospitals, Payers, Providers, Pharma, Patients)
-
Positioning Framework against Competitors and Alternatives after conducting Stakeholder surveys
-
Messaging Toolkit for Sales & Marketing Teams
-
Buyer Persona Alignment — Clinical, IT, Business
Business Benefit:
You get a Healthcare-Ready Product Narrative for each target market and audience, that accelerates sales and positions your solution as a must-have, not a nice-to-have.
Reimbursement Pathways
The healthcare industry is innovating and bringing new solutions to market, yet gap exists in navigating complex reimbursement landscape. Our service serves companies developing novel medical devices, digital health solutions, therapeutics, and diagnostics that require clear reimbursement pathways to succeed, given the critical impact of reimbursement on commercial viability.
Why its Important:
-
Increase Market access: Even clinically superior solutions need to clear their path to reimbursement to de-risks product development and boost commercialization.
-
Evidence based credibility: Payers (public & private), providers, hospitals, public sector and government require evidence-based justification for coverage.
-
Revenue multiplier: drives revenue from increased adoption and scalability.
What you can expect:
-
FDA, CPT and FEDRAMP strategy: clear understanding of need for , type of clearance and process. commercialization.
-
FDA and CPT pre-submission study design: predicate search and study design for FDA clearance. CPT submission to AMA and specialty board.
-
FDA, CPT and FEDRAMP submission: can help support as the clinical head for the study, outcome and submission.
Business Benefits:
Strategy to execution: pathway to market access, adoption and reimbursement.
